AVITA Medical (AVHHL) Cash from Financing Activities (2019 - 2025)
AVITA Medical's (AVHHL) quarterly Cash from Financing Activities came in at $248000.0 in Q4 2025, down 75.71% on a YoY basis from $1.0 million in Q4 2024, and down 98.2% quarter-over-quarter from $13.8 million in Q3 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) Cash from Financing Activities (2019 - 2025) Analysis & Trends
AVITA Medical (AVHHL) has reported Cash from Financing Activities for 7 consecutive years, with $248000.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities fell 75.71% year-over-year to $248000.0; the trailing twelve-month figure through Dec 2025 stood at $14.9 million (up 325.77% YoY), and the FY2025 full-year result was $14.9 million, up 325.77% from the prior year.
- Cash from Financing Activities fell to $248000.0 in Q4 2025 per AVHHL's latest filing, from $13.8 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $64.1 million in Q3 2021 and bottomed at -$64.1 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged $3.5 million across 5 years, with a median of $600000.0 in 2023.
- The widest YoY moves for Cash from Financing Activities: up 1601625.0% in 2021, down 1280120.0% in 2021.
- Over 5 years, Cash from Financing Activities stood at -$64.0 million in 2021, then dropped by 0.08% to -$64.1 million in 2022, then surged by 161.55% to $39.4 million in 2023, then plunged by 97.41% to $1.0 million in 2024, then tumbled by 75.71% to $248000.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $248000.0, $13.8 million, and $559000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.27 Bn | 179.67 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 124.48 Bn | 119.26 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 118.49 Bn | 109.67 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.21 Bn | 101.74 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.93 Bn | 66.39 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.99 Bn | 32.53 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.32 Bn | 30.38 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | -213.50 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 248,000.00 |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 559,000.00 |
| Mar 31, 2025 | 363,000.00 |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 849,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 39.43 Mn |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Mar 31, 2023 | 171,000.00 |
| Dec 31, 2022 | -64.06 Mn |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | -64.01 Mn |
| Sep 30, 2021 | 64.06 Mn |
| Mar 31, 2021 | 64.03 Mn |
| Dec 31, 2020 | -5,000.00 |
| Sep 30, 2020 | -4,000.00 |
| Jun 30, 2020 | 152,000.00 |